Hubei DinglongLtd Past Earnings Performance
Past criteria checks 5/6
Hubei DinglongLtd has been growing earnings at an average annual rate of 35.6%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 17.5% per year. Hubei DinglongLtd's return on equity is 11.5%, and it has net margins of 13.1%.
Key information
35.6%
Earnings growth rate
35.7%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 17.5% |
| Return on equity | 11.5% |
| Net Margin | 13.1% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Does Hubei DinglongLtd (SZSE:300054) Have A Healthy Balance Sheet?
Nov 22
Hubei Dinglong CO.,Ltd.'s (SZSE:300054) 46% Jump Shows Its Popularity With Investors
Oct 08Hubei DinglongLtd's (SZSE:300054) Returns On Capital Are Heading Higher
Sep 08These 4 Measures Indicate That Hubei DinglongLtd (SZSE:300054) Is Using Debt Reasonably Well
Aug 17Market Participants Recognise Hubei Dinglong CO.,Ltd.'s (SZSE:300054) Earnings
Jun 21Hubei DinglongLtd (SZSE:300054) Has More To Do To Multiply In Value Going Forward
May 24Hubei DinglongLtd's (SZSE:300054) Anemic Earnings Might Be Worse Than You Think
Apr 16Hubei Dinglong CO.,Ltd. (SZSE:300054) Released Earnings Last Week And Analysts Lifted Their Price Target To CN¥25.50
Apr 14Is Hubei DinglongLtd (SZSE:300054) Using Too Much Debt?
Mar 30With Hubei Dinglong CO.,Ltd. (SZSE:300054) It Looks Like You'll Get What You Pay For
Feb 28Revenue & Expenses Breakdown
How Hubei DinglongLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 3,220 | 422 | 394 | 435 |
| 30 Jun 24 | 3,027 | 344 | 365 | 423 |
| 31 Mar 24 | 2,828 | 269 | 356 | 394 |
| 31 Dec 23 | 2,667 | 222 | 338 | 377 |
| 30 Sep 23 | 2,639 | 272 | 321 | 372 |
| 30 Jun 23 | 2,568 | 291 | 314 | 346 |
| 31 Mar 23 | 2,698 | 353 | 310 | 336 |
| 31 Dec 22 | 2,721 | 390 | 318 | 313 |
| 30 Sep 22 | 2,660 | 358 | 310 | 299 |
| 30 Jun 22 | 2,572 | 317 | 319 | 276 |
| 31 Mar 22 | 2,406 | 247 | 310 | 265 |
| 31 Dec 21 | 2,356 | 214 | 296 | 252 |
| 30 Sep 21 | 2,214 | -249 | 361 | 238 |
| 30 Jun 21 | 2,102 | -268 | 346 | 215 |
| 31 Mar 21 | 2,054 | -137 | 343 | 186 |
| 31 Dec 20 | 1,817 | -160 | 330 | 162 |
| 30 Sep 20 | 1,606 | 98 | 294 | 130 |
| 30 Jun 20 | 1,401 | 93 | 267 | 121 |
| 31 Mar 20 | 1,161 | -5 | 236 | 115 |
| 31 Dec 19 | 1,149 | 34 | 220 | 114 |
| 30 Sep 19 | 1,146 | 240 | 178 | 111 |
| 30 Jun 19 | 1,224 | 302 | 172 | 110 |
| 31 Mar 19 | 1,292 | 298 | 172 | 112 |
| 31 Dec 18 | 1,338 | 293 | 178 | 103 |
| 30 Sep 18 | 1,443 | 339 | 163 | 97 |
| 30 Jun 18 | 1,528 | 312 | 132 | 131 |
| 31 Mar 18 | 1,626 | 311 | 153 | 104 |
| 31 Dec 17 | 1,700 | 336 | 167 | 84 |
| 30 Sep 17 | 1,632 | 294 | 193 | 58 |
| 30 Jun 17 | 1,624 | 296 | 250 | 0 |
| 31 Mar 17 | 1,457 | 272 | 226 | 0 |
| 31 Dec 16 | 1,306 | 240 | 207 | 0 |
| 30 Sep 16 | 1,215 | 218 | 174 | 0 |
| 30 Jun 16 | 1,083 | 186 | 152 | 0 |
| 31 Mar 16 | 1,051 | 163 | 143 | 0 |
| 31 Dec 15 | 1,050 | 159 | 143 | 0 |
| 30 Sep 15 | 1,007 | 155 | 143 | 0 |
| 30 Jun 15 | 980 | 145 | 137 | 0 |
| 31 Mar 15 | 986 | 145 | 134 | 0 |
| 31 Dec 14 | 919 | 134 | 122 | 0 |
| 30 Sep 14 | 848 | 122 | 103 | 0 |
| 30 Jun 14 | 710 | 104 | 83 | 0 |
| 31 Mar 14 | 563 | 87 | 69 | 0 |
| 31 Dec 13 | 491 | 75 | 61 | 0 |
Quality Earnings: 300054 has high quality earnings.
Growing Profit Margin: 300054's current net profit margins (13.1%) are higher than last year (10.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300054's earnings have grown significantly by 35.6% per year over the past 5 years.
Accelerating Growth: 300054's earnings growth over the past year (55.4%) exceeds its 5-year average (35.6% per year).
Earnings vs Industry: 300054 earnings growth over the past year (55.4%) exceeded the Chemicals industry -5.3%.
Return on Equity
High ROE: 300054's Return on Equity (11.5%) is considered low.